High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy. (Q44477265)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy. |
scientific article |
Statements
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy (English)
Anthony Goldstone
Monica Bellei
Pauline Brice
Maura Brugiatelli
Arnon Nagler
Christian Gisselbrecht
Luciano Moretti
Philippe Colombat
Francesco Fabbiano
Nicola Di Renzo
Angelo Michele Carella
EBMT/GISL/ANZLG/SFGM/GELA Intergroup HD01 Trial